骨髓微环境中的衰老:与治疗相关的骨髓瘤发展的一个驱动因素
Angelo Jose Guilatco1,2, Mithun Vinod Shah1, Megan Moore Weivoda1
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Journal of bone oncology
|July 29, 2024
概括
与治疗相关的骨髓瘤 (t-MN) 正在增加. 细胞毒性疗法在骨髓微环境中引起衰老,有助于t-MN的发展,并提供新的治疗点.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 细胞衰老 细胞衰老
背景情况:
- 与治疗相关的骨髓瘤 (t-MN) 是一个重大的临床挑战.
- 细胞毒性疗法虽然对治疗恶性瘤至关重要,但可以诱导细胞损伤.
- 骨髓微环境 (BMME) 对于血液形成至关重要,并且可以受到治疗的影响.
研究的目的:
- 审查BMME衰老在t-MN.病原发生中的作用.
- 探索最近的研究,将治疗诱导的衰老与t-MN发展联系起来.
- 确定针对BMME衰老的潜在治疗策略.
主要方法:
- 关于t-MN和BMME最近研究的文献综述.
- 对链接细胞毒性治疗,衰老和血液形成机制的分析.
- 综合发现,提出治疗干预措施.
主要成果:
- 细胞毒性疗法在BMME中诱导衰老.
- BMME衰老有助于t-MN的发展.
- 在BMME中的衰老细胞可以破坏正常的血液形成.
结论:
- BMME衰老是t-MN发病的一个关键因素.
- 向BMME中的衰老细胞可能为t-MN提供新的治疗途径.
- 需要进一步的研究来将这些发现转化为临床实践.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Bone Marrow Sampling and Transplants
318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K


